U.S. market Open. Closes in 5 hours 58 minutes

MDNA | Medicenna Therapeutics Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses16.30M22.47M17.39M8.24M4.73M7.42M7.70M1.20M833.00767.00
Selling, General & Admin6.99M7.72M6.49M2.49M2.21M3.00M4.02M469.71K253.00112.00
Research & Development9.30M14.72M10.87M5.87M3.02M5.09M4.23M771.41K766.00860.00
Other Operating Expenses5.00K37.00K40.00K-117.48K-499.37KN/AN/AN/AN/AN/A
Operating Income-16.30M-22.30M-17.19M-8.21M-4.73M-7.38M-7.67M-1.20M-829.00-762.00
Other Expenses / Income6.25M-104.00K106.00K-32.07K19.25K-40.62K-1.72M-134.40K-4.00-3.00
Before Tax Income-10.05M-22.58M-17.29M-8.28M-4.71M-7.47M-7.63M-1.33M-833.00-765.00
Income Tax Expenses-11.60M69.00K-106.00K32.27K19.25K40.62K60.00441.00N/A-3.00
Net Income1.55M-22.65M-17.18M-8.31M-4.71M-7.47M-7.63M-1.33M-833.00-765.00
Interest ExpensesN/A69.00KN/AN/AN/AN/A60.00441.000N/A
Basic Shares Outstanding64.74M54.29M49.66M31.90M25.67M24.37M16.91M16.00M15.60K15.60K
Diluted Shares Outstanding64.74M54.29M49.66M31.90M25.67M24.37M16.91M16.00M15.60K15.60K
EBITDA-16.30M-22.43M-17.15M-8.24M-4.72M-7.37M-7.66M-1.20M-828.00-3.00
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-10.05M-22.51M-17.29M-8.28M-4.69M-7.42M-7.63M-1.33M-833.00-769.00
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙